Rossari Biotech Limited

Rossari Biotech Limited (ROSSARI) is a micro-cap Chemicals company valued at ₹2,520 crore operating in Specialty Chemicals on the NSE and BSE.

Recent price move

Rossari Biotech Limited last traded at ₹453.55, up 3.75% on the day.

Recent developments

On 2026-07-10, the company announced a dividend of ₹0.50 per share, effective from that date. Promoter holding remained at 68.14% as of 2026-06-30, while foreign institutional holding decreased by 0.16 percentage points and domestic institutional holding fell by 3.56 percentage points in the quarter.

Financial performance

Rossari Biotech's business has grown steadily, with annual revenue rising 15.2% year-over-year and net profit increasing 9.7%. The latest quarter saw revenue rise 28.2% compared to the same quarter a year earlier, though net profit growth slowed to 3.2%.

Valuation multiples

The stock trades at 16.8 times earnings, 1.87 times book value. It yields 0.1%.

Things to watch

The net profit margin narrowed by 0.3 percentage points to 6.2%, and the stock is 38.1% below its 52-week high. Domestic institutional holding dropped significantly in the quarter, indicating potential selling pressure.

Where it stands

Rossari Biotech has maintained consistent revenue and profit growth over the past five years, with recent quarterly results showing strong revenue expansion. The company's net profit margin has slightly declined, and the stock is trading below its 52-week high, reflecting recent underperformance.

Summarised by DocStoX's model on 2026-10-04 from company filings, exchange data and news. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.